• 621 Citations
  • 12 h-Index
20102020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Strati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 68 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Achieving complete remission in CLL patients treated with ibrutinib: Clinical significance and predictive factors

Strati, P., Schlette, E. J., Solis Soto, L. M., Duenas, D. E., Sivina, M., Kim, E., Keating, M. J., Wierda, W. G., Ferrajoli, A., Kantarjian, H., Estrov, Z., Jain, N., Thompson, P. A., Wistuba, I. I. & Burger, J. A., Feb 13 2020, In : Blood. 135, 7, p. 510-513 4 p.

Research output: Contribution to journalLetter

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Strati, P., Nastoupil, L. J., Davis, R. E., Fayad, L. E., Fowler, N., Hagemeister, F. B., Kwak, L., Oki, Y., Wang, M., Westin, J., Ruben, C. E., Wesson, E. T., Piekarz, R., Fanale, M. A. & Lee, H. J., Jan 1 2020, In : Haematologica. 105, 1, p. E26-E28

Research output: Contribution to journalLetter

Open Access
2 Scopus citations

Erratum: Venetoclax for AML: Changing the treatment paradigm(Blood Advances (2019) 3:24 (4326-4335) DOI: 10.1182/bloodadvances.2019000937)

Pollyea, D. A., Amaya, M., Strati, P. & Konopleva, M. Y., Mar 24 2020, In : Blood Advances. 4, 6, 1 p.

Research output: Contribution to journalComment/debate

Open Access